MMSI
Merit Medical Systems Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Merit Medical Systems (MMSI) Stock: Buy, Sell, or Hold?
$87.73
-0.08 (-0.09%)
▼
5d:
-3.2%
30d:
-0.47%
90d:
-3.06%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (84%)
Quality Score
61/100
Position
FAIR
30-Day Fair Range
$86.03 – $92.02
Position: FAIR
Forward P/E & Valuation
18.8x
FAIR
vs 18.0x historical avg
Wall Street Target
$107.00
+21.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$83.56 / $93.78
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: MMSI shows positive signals but monitor for confirmation. Market pricing in 1.5% annual growth which appears achievable. Moderate conviction.
Get Alerted When MMSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$110.56
Based on 5.6% avg growth
INTRINSIC VALUE TODAY
$68.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MMSI is currently trading at $87.73, which is considered fair relative to its 30-day fair value range of $86.03 to $92.02. The stock's valuation (Forward PE: 18.8) is in line with its historical norms (18.0). At these levels, the market is pricing in 1.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MMSI is in a strong uptrend. Immediate support is located at $83.56, while resistance sits at $93.78.
Market Sentiment: MMSI scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.00 (+21.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MMSI is in a strong uptrend. Immediate support is located at $83.56, while resistance sits at $93.78.
Market Sentiment: MMSI scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.00 (+21.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$86.03 -
$92.02
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.3%
Trading Range & Key Levels
30-Day Trading Range
$86.03 -
$92.02
Current vs Trading Range
FAIR
Support Level
$83.56
Resistance Level
$93.78
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.9% below Wall St target ($107.00)
- NEUTRAL: Market pricing in 1.5% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 65/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
18.81
Wall Street Target
$107.00
(+21.9%)
Revenue Growth (YoY)
8.4%
Earnings Growth (YoY)
52.2%
Profit Margin
9.9%
Valuation Premium vs History
+1.5% premium
PE vs Historical
18.8 vs 18.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$89.13
(+2%)
2-Year Target
$90.46
(+3%)
3-Year Target
$91.82
(+5%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$87.86
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.3%)
$114.49
(+30%)
Base:
(SPY PE: 18.8, Growth: 7.3%)
$108.44
(+24%)
Bear:
(PE: 16.0, Growth: 7.3%)
$92.18
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 33.12 | Current EPS (TTM): $2.67
Bull Case
$170.04
(+94%)
Analyst growth 74.8%, PE expands to 36.4
Base Case
$154.58
(+76%)
Market implied 74.8%, PE stable at 33.1
Bear Case
$60.13
(-32%)
Severe decline -20.0%, PE contracts to 28.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share MMSI Analysis
Share this live MMSI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MMSI)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
GE Healthcare (GEHC) announced five new global clinical collaborations to evaluate its StarGuide GX digital SPECT/CT system, aiming to advance quantitative imaging and theranostics applications. StockTwits shows 100.0% bullish sentiment.
Key Retail Themes:
GEHC's expansion in theranostics imaging
Global clinical collaborations to evaluate StarGuide GX
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:41 PM ET
Data refreshes hourly during market hours. Next update: 2:41 PM
Data refreshes hourly during market hours. Next update: 2:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MMSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MMSI Research Pages